Several possible studies
Story checked
Here's why experts say now is an ideal time to protect yourself from flu (opens in a new tab)
medicalxpress.com · 2026-10-02
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Here's why experts say now is an ideal time to protect yourself from flu
medicalxpress.com · 2026-10-02
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 6Not checkedOctober is an ideal time to get a flu shot, and experts say vaccination should happen soon before influenza starts spreading widely.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 6Not checkedJust about everyone starting at age 6 months should get vaccinated against flu, with especially strong emphasis on older adults, pregnant women, young children, and people with chronic or immune-compromising conditions.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 6Not checkedThe vaccines do not block all flu infections, but they help prevent the worst outcomes; the article says older-adult hospitalizations were decreased by 31% last year, according to the Vaccine Integrity Project.View evidenceHide evidence
As stated31%
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 6Not checkedA study found Moderna's mFlusiva was 27% more effective against symptomatic illness among 50- to 64-year-olds than a standard flu shot.View evidenceHide evidence
As stated27% more effective
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 6Not checkedThe article says COVID-19 shots are still recommended by family physicians for all adults, especially seniors and those with other risk factors, and that last fall's COVID-19 shots cut hospitalization risk by 53% in seniors.View evidenceHide evidence
As stated53%
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 6Not checkedRSV can be severe or life-threatening for infants and older adults, and the article says medical groups recommend RSV vaccination for certain older adults, high-risk younger adults, and during late pregnancy to protect infants.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Crossref · 15 candidate papers
mRNA-based seasonal influenza vaccines: an overview of immunogenicity, efficacy, and safety.
Frontiers in Immunology · 2026 · PubMed
Decision letter for "Burden of severe illness associated with laboratory confirmed influenza in adults aged 50–64 years: A rapid review"
2021 · Crossref
Estimating the Relative Vaccine Efficacy of mRNA-1010 to High-Dose Influenza Vaccine in Adults ≥65 Years Using a Correlate of Protection Framework.
Vaccines · 2026 · PubMed
Burden of severe illness associated with laboratory confirmed influenza in adults aged 50-64 years: a rapid review
2021 · Crossref
mFLUSIVA - an mRNA-based influenza vaccine.
The Medical Letter on Drugs and Therapeutics · 2026 · PubMed
And 10 more candidates considered.